Received Mar 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | 3 | UNK | — |
we missed the booster; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 5-year-old male patient who received Men B NVS (Bexsero) for prophylaxis. Previously administered products included Bexsero (received first dose of Bexsero at 19 months ) and Bexsero (received second dose of Bexsero at 21 months old). On an unknown date, the patient did not receive the 3rd dose of Bexsero. On an unknown date, an unknown time after receiving Bexsero, the patient experienced incomplete course of vaccination (Verbatim: we missed the booster). The outcome of the incomplete course of vaccination was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-MAR-2025 The patient was the son of the reporter. The reporter reported that the patient had the bexero vaccine when he was 19 months and 21 months old. At the time reporting he was 5 and they missed the booster. The reporter asked could he have it at the time of reporting The reporter reported that it was recommened 12 to 23 months after the second dose. Till the time of reporting the patient did not receive the third dose of Bexsero which led to incomplete course of vaccination.